Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Letters in peptide science

• Publication date

  2003-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10989-004-2431-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.

  2009cited by this paper
• Simultaneous lipidation of a characterized peptide mixture by chemoselective ligation.

  2003cited by this paper
• Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens

  2003cited by this paper
• Acute cerebellar ataxia in a toddler: case report and literature review.

  2003cited by this paper
• Molecular basis of group A streptococcal virulence.

  2003cited by this paper
• Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

  2002cited by this paper
• A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies

  2002cited by this paper
• The terminology of guanidine formation

  2002cited by this paper
• Recent advances in mucosal vaccines and adjuvants.

  2002cited by this paper
• Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid‐core peptide technology

  2002cited by this paper
• Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

  2002cited by this paper
• Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

  2001cited by this paper
• Carbohydrate-based templates for synthetic vaccines and drug delivery

  2001cited by this paper
• Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations.

  2001cited by this paper
• Lipopeptide presentation pathway in dendritic cells.

  2001cited by this paper
• Manipulating the immune system: humoral versus cell-mediated immunity.

  2001cited by this paper
• A lipophilic adjuvant carrier system for antigenic peptides

  2001cited by this paper
• Towards synthetic vaccines built on carbohydrate cores

  2001cited by this paper
• Mechanisms of vaccine adjuvanticity at mucosal surfaces

  2000cited by this paper
• Endocytosis of an HIV‐derived lipopeptide into human dendritic cells followed by class I‐restricted CD8+ T lymphocyte activation

  2000cited by this paper
• Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine

  2000cited by this paper
• Induction of Pro- and Anti-Inflammatory Cytokines by Borrelia burgdorferi Lipoproteins in Monocytes Is Mediated by CD14

  1999cited by this paper
• Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.

  1999cited by this paper
• Preventing rheumatic heart disease in Australia

  1998cited by this paper
• Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations.

  1998cited by this paper
• Lipopeptide immunization without adjuvant induces potent and long‐lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees

  1997cited by this paper
• Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.

  1997cited by this paper
• Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory

  1996cited by this paper
• Recent advances in multiple antigen peptides.

  1996cited by this paper
• Pimelautide or trimexautide as built-in adjuvants associated with an HIV-1-derived peptide: synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocyte-mediated response.

  1995cited by this paper
• Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci.

  1994cited by this paper
• Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.

  1994cited by this paper
• A novel chemical approach to drug delivery: lipidic amino acid conjugates.

  1994cited by this paper
• A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids

  1993cited by this paper
• Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.

  1992cited by this paper
• Acute rheumatic fever and rheumatic heart disease in a rural central Australian Aboriginal community

  1990cited by this paper
• Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers

  1990cited by this paper
• In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

  1989cited by this paper
• Protective and autoimmune epitopes of streptococcal M proteins.

  1988cited by this paper
• Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

  1988cited by this paper
• Increased Production of Specific Antibodies by Presentation of the Antigen Determinants with Covalently Coupled Lipopetide Mitogens

  1985cited by this paper
• Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein.

  1983cited by this paper
• Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

  1981cited by this paper

• Lipo-Peptides/Saccharides for Peptide Vaccine Delivery

  2013cites this paper
• Strategies in Oral Immunization

  2009cites this paper
• Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery

  2009cites this paper
• Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

  2006cites this paper